Genalyte
PrivateLast Round
Series C
Extension
Apr 21, 2023
Est. Valuation
$302.19M
Total Funding Raised
$74.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genalyte is a healthcare technology company that develops and provides diagnostic platforms for rapid, real-time blood testing at the point of care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Sensors, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genalyte Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Genalyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 21, 2023 | ||||
| VC Round | Jan 11, 2021 | ||||
| VC Round | Nov 21, 2016 | ||||
| Series C | Aug 18, 2015 | ||||
| Grant | Aug 20, 2013 | ||||
Grant | Dec 11, 2012 |
Genalyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series C Extension, VC Round, Series B |
| National Cancer Institute | Grant |
| Khosla Ventures | Series C Extension, VC Round, Series C |
| Provenio Capital | Series C Extension, VC Round |
| Boutique Venture Partners | Series C Extension |
| Invus Opportunities | Series C Extension |
| HBM Healthcare Investments | Series C Extension, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Merlin platform for diagnostic testing is in development.
- Apr 16, 2025
Attended Abu Dhabi Global Health Week 2025 and announced a strategic partnership.
Genalyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genalyte's valuation, stock price, and market status.